Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CANALEJO, A.
Right arrow Articles by RODRÍGUEZ, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CANALEJO, A.
Right arrow Articles by RODRÍGUEZ, M.
J Am Soc Nephrol 11:1865-1872, 2000
© 2000 American Society of Nephrology

The In Vitro Effect of Calcitriol on Parathyroid Cell Proliferation and Apoptosis

ANTONIO CANALEJO*, YOLANDA ALMADÉN*, VICENTE TORREGROSA{dagger}, JOSE C. GOMEZ-VILLAMANDOS{ddagger}, BLANCA RAMOS§, JOSE M. CAMPISTOL{dagger}, ARNOLD J. FELSENFELD|| and MARIANO RODRÍGUEZ*

* Research Unit and Nephrology Service, Reina Sofia University Hospital, Córdoba
{dagger} Nephrology Service, Hospital Clinic, Barcelona
{ddagger} Department of Pathology, Veterinary Faculty, University of Córdoba, Córdoba
§ Nephrology Service, Carlos Haya Hospital, Malaga, Spain
|| Department of Medicine, West Los Angeles VA Medical Center and UCLA, Los Angeles, California.

Correspondence to Dr. Mariano Rodriguez, Unidad de Investigación, Hospital Reina Sofia, Avda Menendez Pidal s/n, 14004 Cordoba, Spain. Phone: 34-957-217229; Fax: 34-957-202542; E-mail: mrodriguez{at}sofia.hrs.sas.cica.es

Abstract. Calcitriol treatment is used to reduce parathyroid hormone levels in azotemic patients with secondary hyperparathyroidism (HPT). Whether long-term calcitriol administration reduces parathyroid gland size in patients with severe secondary hyperparathyroidism is not clear. The aim of the study was to evaluate in vitro the effect of calcitriol on parathyroid cell proliferation and apoptosis in normal parathyroid glands and in adenomatous and hyperplastic human parathyroid glands. Freshly harvested parathyroid glands from normal dogs and hyperplastic and adenomatous glands from patients with secondary (2°) and primary (1°) HPT undergoing parathyroidectomy were studied. Flow cytometry was used to quantify the cell cycle and apoptosis of parathyroid cells. Apoptosis was also evaluated by DNA electrophoresis and light and electron microscopy. In normal dog parathyroid glands, culture with calcitriol (10-10 to 10-7 M) for 24 h produced a dose-dependent inhibitory effect on the progression of cells into the cell cycle and into apoptosis. When glands from patients with 2°HPT were cultured for 24 h, only high calcitriol concentrations (10-7 M) inhibited the progression through the cell cycle and the induction of apoptosis. In parathyroid adenomas (1°HPT), even a high concentration of calcitriol (10-7 M) had no significant effect on the cell cycle or apoptosis. The present study shows that in vitro, calcitriol inhibits in a dose-dependent manner in normal parathyroid glands both parathyroid cell proliferation and apoptosis. However, in secondary hyperplasia, only high concentrations of calcitriol inhibited cell proliferation and apoptosis. In 1°HPT, even high concentrations of calcitriol had no effect. Because calcitriol simultaneously inhibits both cell proliferation and apoptosis, a reduction in the parathyroid gland mass may not occur as a direct effect of calcitriol treatment.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
N. Carrillo-Lopez, D. Alvarez-Hernandez, I. Gonzalez-Suarez, P. Roman-Garcia, J. M. Valdivielso, J. L. Fernandez-Martin, and J. B. Cannata-Andia
Simultaneous changes in the calcium-sensing receptor and the vitamin D receptor under the influence of calcium and calcitriol
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3479 - 3484.
[Abstract] [Full Text] [PDF]


Home page
NDT PlusHome page
K. Shiizaki, I. Hatamura, S. Negi, E. Nakazawa, R. Tozawa, S. Izawa, T. Akizawa, and E. Kusano
Cellular changes following direct vitamin D injection into the uraemia-induced hyperplastic parathyroid gland
NDT Plus, August 1, 2008; 1(suppl_3): iii42 - iii48.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Shiizaki, I. Hatamura, S. Negi, T. Sakaguchi, F. Saji, I. Imazeki, E. Kusano, T. Shigematsu, and T. Akizawa
Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1529 - 1536.
[Abstract] [Full Text] [PDF]


Home page
NDT PlusHome page
D. Riccardi and D. Martin
The Role of the Calcium-Sensing Receptor in the Pathophysiology of Secondary Hyperparathyroidism
NDT Plus, January 1, 2008; 1(suppl_1): i7 - i11.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Drueke, D. Martin, and M. Rodriguez
Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1828 - 1839.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B Moosgaard, P Vestergaard, L Heickendorff, F Melsen, P Christiansen, and L Mosekilde
Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
Eur. J. Endocrinol., August 1, 2006; 155(2): 237 - 244.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
K. Olgaard and E. Lewin
Can Hyperparathyroid Bone Disease Be Arrested or Reversed?
Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 367 - 373.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Shiizaki, S. Negi, I. Hatamura, T. Sakaguchi, F. Saji, K. Kunimoto, M. Mizobuchi, I. Imazeki, A. Ooshima, and T. Akizawa
Biochemical and Cellular Effects of Direct Maxacalcitol Injection into Parathyroid Gland in Uremic Rats
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 97 - 108.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Okuno, E. Ishimura, K. Kitatani, H. Chou, K. Nagasue, K. Maekawa, T. Izumotani, T. Yamakawa, Y. Imanishi, T. Shoji, et al.
Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism
Nephrol. Dial. Transplant., December 1, 2003; 18(12): 2613 - 2621.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Silver, R. Kilav, and T. Naveh-Many
Mechanisms of secondary hyperparathyroidism
Am J Physiol Renal Physiol, September 1, 2002; 283(3): F367 - F376.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Jara, S. Gonzalez, A. J. Felsenfeld, C. Chacon, A. Valdivieso, R. Jalil, and B. Chuaqui
Failure of high doses of calcitriol and hypercalcaemia to induce apoptosis in hyperplastic parathyroid glands of azotaemic rats
Nephrol. Dial. Transplant., March 1, 2001; 16(3): 506 - 512.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP